Lv5
1093 积分 2020-11-05 加入
Does TRIANGLE take down transplantation in mantle cell lymphoma?
22分钟前
待确认
Addition of autologous stem-cell transplantation to an ibrutinib-containing first-line treatment in patients aged 18–65 years with mantle cell lymphoma (TRIANGLE): 4·5-year follow-up of a three-arm, randomised, open-label, phase 3 superiority trial of the European MCL Network
23分钟前
已完结
Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma Network
23分钟前
已完结
Zanubrutinib, obinutuzumab, and venetoclax for first-line treatment of mantle cell lymphoma with a TP53 mutation
7天前
已完结
Acalabrutinib Plus Bendamustine-Rituximab in Untreated Mantle Cell Lymphoma
7天前
已完结
Ibrutinib plus Bendamustine and Rituximab in Untreated Mantle-Cell Lymphoma
7天前
已完结
Efficacy and safety of iguratimod in patients with primary Sjögren’s syndrome: a multicentre randomised controlled trial
8天前
已完结
Efficacy and safety of iguratimod in patients with primary Sjögren’s syndrome: a multicentre randomised controlled trial
9天前
已完结
Rituximab for Treatment of Advanced Extranodal Marginal Zone B Cell Lymphoma of the Mucosa-Associated Lymphoid Tissue Lymphoma
9天前
已完结
Correction to Lancet Rheumatol 2021; 3: e789–97
11天前
已关闭
皖公网安备34019202002308
